BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11853673)

  • 1. Kre1p, the plasma membrane receptor for the yeast K1 viral toxin.
    Breinig F; Tipper DJ; Schmitt MJ
    Cell; 2002 Feb; 108(3):395-405. PubMed ID: 11853673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer-toxin-resistant kre12 mutants of Saccharomyces cerevisiae: genetic and biochemical evidence for a secondary K1 membrane receptor.
    Schmitt MJ; Compain P
    Arch Microbiol; 1995 Dec; 164(6):435-43. PubMed ID: 8588746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different action of killer toxins K1 and K2 on the plasma membrane and the cell wall of Saccharomyces cerevisiae.
    Novotná D; Flegelová H; Janderová B
    FEMS Yeast Res; 2004 Sep; 4(8):803-13. PubMed ID: 15450187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast Kre1p is GPI-anchored and involved in both cell wall assembly and architecture.
    Breinig F; Schleinkofer K; Schmitt MJ
    Microbiology (Reading); 2004 Oct; 150(Pt 10):3209-18. PubMed ID: 15470101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure of the cell wall receptor for killer toxin KT28 in Saccharomyces cerevisiae.
    Schmitt M; Radler F
    J Bacteriol; 1988 May; 170(5):2192-6. PubMed ID: 2834332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K1 killer toxin, a pore-forming protein from yeast.
    Bussey H
    Mol Microbiol; 1991 Oct; 5(10):2339-43. PubMed ID: 1724277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of K1 Toxin Derivatives in Saccharomyces cerevisiae Mimics Treatment with Exogenous Toxin and Provides a Useful Tool for Elucidating K1 Mechanisms of Action and Immunity.
    Gier S; Schmitt MJ; Breinig F
    Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29076990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular target for viral killer toxin: TOK1 potassium channels.
    Ahmed A; Sesti F; Ilan N; Shih TM; Sturley SL; Goldstein SA
    Cell; 1999 Oct; 99(3):283-91. PubMed ID: 10555144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to K1 killer toxin: internal TOK1 blockade.
    Sesti F; Shih TM; Nikolaeva N; Goldstein SA
    Cell; 2001 Jun; 105(5):637-44. PubMed ID: 11389833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of Saccharomyces cerevisiae mutants with a different degree of resistance to killer toxins K1 and K2.
    Flegelová H; Novotná D; Vojtísková K; Janderová B
    FEMS Yeast Res; 2002 Mar; 2(1):73-9. PubMed ID: 12702323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast K1 killer toxin forms ion channels in sensitive yeast spheroplasts and in artificial liposomes.
    Martinac B; Zhu H; Kubalski A; Zhou XL; Culbertson M; Bussey H; Kung C
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6228-32. PubMed ID: 1696721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast Kre1p is a cell surface O-glycoprotein.
    Roemer T; Bussey H
    Mol Gen Genet; 1995 Nov; 249(2):209-16. PubMed ID: 7500943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the functional domains of yeast K1 killer toxin.
    Zhu H; Bussey H
    Mol Cell Biol; 1991 Jan; 11(1):175-81. PubMed ID: 1702512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic studies of killer toxin K1 binding to yeast cells indicate two receptor populations.
    Kurzweilová H; Sigler K
    Arch Microbiol; 1994; 162(3):211-4. PubMed ID: 7979876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence of the M28 dsRNA: preprotoxin is processed to an alpha/beta heterodimeric protein toxin.
    Schmitt MJ; Tipper DJ
    Virology; 1995 Nov; 213(2):341-51. PubMed ID: 7491759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast β-1,6-glucan is a primary target for the Saccharomyces cerevisiae K2 toxin.
    Lukša J; Podoliankaitė M; Vepštaitė I; Strazdaitė-Žielienė Ž; Urbonavičius J; Servienė E
    Eukaryot Cell; 2015 Apr; 14(4):406-14. PubMed ID: 25710965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and molecular approaches to synthesis and action of the yeast killer toxin.
    Bussey H; Boone C; Zhu H; Vernet T; Whiteway M; Thomas DY
    Experientia; 1990 Feb; 46(2):193-200. PubMed ID: 2406163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel yeast gene, RHK1, is involved in the synthesis of the cell wall receptor for the HM-1 killer toxin that inhibits beta-1,3-glucan synthesis.
    Kimura T; Kitamoto N; Kito Y; Iimura Y; Shirai T; Komiyama T; Furuichi Y; Sakka K; Ohmiya K
    Mol Gen Genet; 1997 Mar; 254(2):139-47. PubMed ID: 9108275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H/KDEL receptors mediate host cell intoxication by a viral A/B toxin in yeast.
    Becker B; Blum A; Gießelmann E; Dausend J; Rammo D; Müller NC; Tschacksch E; Steimer M; Spindler J; Becherer U; Rettig J; Breinig F; Schmitt MJ
    Sci Rep; 2016 Aug; 6():31105. PubMed ID: 27493088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the lag phase in K1 killer toxin action on sensitive yeast cells.
    Kurzweilová H; Sigler K
    Folia Microbiol (Praha); 1995; 40(2):213-15. PubMed ID: 8851565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.